Keywords: Merck & Co, Zioptan, USA, FDA, Ophthalmic solution, Glaucoma, Saflutan

FDA approves Merck & Co’s Zioptan

Article | 14 February 2012

Print This

The US Food and Drug Administration) has approved drug giant Merck & Co’s (NYSE: MRK) Zioptan (tafluprost ophthalmic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in